Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
- PMID: 31258105
- PMCID: PMC6712955
- DOI: 10.1017/S0033291719001454
Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels
Abstract
Background: Peripheral low-grade inflammation in depression is increasingly seen as a therapeutic target. We aimed to establish the prevalence of low-grade inflammation in depression, using different C-reactive protein (CRP) levels, through a systematic literature review and meta-analysis.
Methods: We searched the PubMed database from its inception to July 2018, and selected studies that assessed depression using a validated tool/scale, and allowed the calculation of the proportion of patients with low-grade inflammation (CRP >3 mg/L) or elevated CRP (>1 mg/L).
Results: After quality assessment, 37 studies comprising 13 541 depressed patients and 155 728 controls were included. Based on the meta-analysis of 30 studies, the prevalence of low-grade inflammation (CRP >3 mg/L) in depression was 27% (95% CI 21-34%); this prevalence was not associated with sample source (inpatient, outpatient or population-based), antidepressant treatment, participant age, BMI or ethnicity. Based on the meta-analysis of 17 studies of depression and matched healthy controls, the odds ratio for low-grade inflammation in depression was 1.46 (95% CI 1.22-1.75). The prevalence of elevated CRP (>1 mg/L) in depression was 58% (95% CI 47-69%), and the meta-analytic odds ratio for elevated CRP in depression compared with controls was 1.47 (95% CI 1.18-1.82).
Conclusions: About a quarter of patients with depression show evidence of low-grade inflammation, and over half of patients show mildly elevated CRP levels. There are significant differences in the prevalence of low-grade inflammation between patients and matched healthy controls. These findings suggest that inflammation could be relevant to a large number of patients with depression.
Keywords: C-reactive protein; CRP; depression; immunopsychiatry; inflammation; low-grade inflammation; meta-analysis; mood; prevalence; review.
Figures




Similar articles
-
Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals.JAMA Psychiatry. 2013 Feb;70(2):176-84. doi: 10.1001/2013.jamapsychiatry.102. JAMA Psychiatry. 2013. PMID: 23266538
-
Inflammation and remission in older patients with depression treated with electroconvulsive therapy; findings from the MODECT study✰.J Affect Disord. 2019 Sep 1;256:509-516. doi: 10.1016/j.jad.2019.06.040. Epub 2019 Jul 1. J Affect Disord. 2019. PMID: 31279250
-
Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.J Affect Disord. 2016 Feb;191:209-15. doi: 10.1016/j.jad.2015.11.017. Epub 2015 Nov 26. J Affect Disord. 2016. PMID: 26674214
-
Peripheral levels of C-reactive protein, tumor necrosis factor-α, interleukin-6, and interleukin-1β across the mood spectrum in bipolar disorder: A meta-analysis of mean differences and variability.Brain Behav Immun. 2021 Oct;97:193-203. doi: 10.1016/j.bbi.2021.07.014. Epub 2021 Jul 28. Brain Behav Immun. 2021. PMID: 34332041
-
Cancer-related inflammation and depressive symptoms: Systematic review and meta-analysis.Cancer. 2022 Jul 1;128(13):2504-2519. doi: 10.1002/cncr.34193. Epub 2022 Apr 13. Cancer. 2022. PMID: 35417925 Free PMC article.
Cited by
-
Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric Depression.Drugs Aging. 2021 Jun;38(6):451-467. doi: 10.1007/s40266-021-00858-2. Epub 2021 Apr 29. Drugs Aging. 2021. PMID: 33913114 Review.
-
Emotional states predict cellular immune system activity under conditions of life as it is lived: A multivariate time-series analysis approach.PLoS One. 2023 Nov 9;18(11):e0290032. doi: 10.1371/journal.pone.0290032. eCollection 2023. PLoS One. 2023. PMID: 37943877 Free PMC article.
-
Cerebrospinal fluid proteome evaluation in major depressive disorder by mass spectrometry.BMC Psychiatry. 2020 Oct 1;20(1):481. doi: 10.1186/s12888-020-02874-9. BMC Psychiatry. 2020. PMID: 32998701 Free PMC article.
-
Associations Between Neuropsychiatric Symptoms and Inflammation in Neurodegenerative Dementia: A Systematic Review.J Inflamm Res. 2024 Sep 7;17:6113-6141. doi: 10.2147/JIR.S385825. eCollection 2024. J Inflamm Res. 2024. PMID: 39262651 Free PMC article. Review.
-
Microglia and Microbiome-Gut-Brain Axis.Adv Neurobiol. 2024;37:303-331. doi: 10.1007/978-3-031-55529-9_17. Adv Neurobiol. 2024. PMID: 39207699 Review.
References
-
- Almeida OP, Flicker L, Norman P, Hankey GJ, Vasikaran S, van Bockxmeer FM and Jamrozik K (2007) Association of cardiovascular risk factors and disease with depression in later life. The American Journal of Geriatric Psychiatry 15, 506–513. - PubMed
-
- Benedetti F, Lucca A, Brambilla F, Colombo C and Smeraldi E (2002) Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance. Progress in Neuro-psychopharmacology and Biological Psychiatry 26, 1167–1170. - PubMed
-
- Benros ME, Waltoft BL, Nordentoft M, Østergaard SD, Eaton WW, Krogh J and Mortensen PB (2013) Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study. JAMA Psychiatry 70, 812–820. - PubMed
-
- Carvalho L, Torre J, Papadopoulos A, Poon L, Juruena M, Markopoulou K, Cleare A and Pariante C (2013) Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system. Journal of Affective Disorders 148, 136–140. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous